You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天津就生物醫藥產業高質量發展提10類支持政策
阿思達克 06-28 14:22

天津市市場監管委、天津市藥監局、天津市知識產權局昨日(27日)召開「支持生物醫藥產業高質量發展改革措施」新聞發布會,發布《關於進一步支持我市生物醫藥產業高質量發展的若干意見》,提出10類支持政策。

該意見提出,積極承接北京非首都功能疏解,吸引創新型、龍頭型、互補型醫療器械生產企業落戶天津,對滿足生產條件和產品安全性底線要求的,直接採信北京許可結論、直接發證,最大限度簡化審評審批。

同時,將藥品再註冊事項審批時限由6個月壓縮至15日,藥品審評事項時限由40日壓縮至20日,將藥品檢驗事項辦理時限由60日壓縮至30日;將大力支持創新葯生產企業落地生產,針對國家藥品監管局直接受理和審批的新藥,實施早期介入、全程跟蹤等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account